Logo image of 1SXP.DE

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price, Quote, News and Overview

FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR

28.5  +0.4 (+1.42%)

1SXP.DE Quote, Performance and Key Statistics

SCHOTT PHARMA AG& CO KGAA

FRA:1SXP (5/30/2025, 7:00:00 PM)

28.5

+0.4 (+1.42%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High36.88
52 Week Low18.5
Market Cap4.29B
Shares150.61M
Float34.64M
Yearly Dividend0.15
Dividend Yield0.57%
PE29.08
Fwd PE22.74
Earnings (Next)08-12 2025-08-12
IPO09-28 2023-09-28


1SXP.DE short term performance overview.The bars show the price performance of 1SXP.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

1SXP.DE long term performance overview.The bars show the price performance of 1SXP.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -0.5 -1 -1.5 -2 -2.5

The current stock price of 1SXP.DE is 28.5 EUR. In the past month the price increased by 13.32%. In the past year, price decreased by -2.73%.

SCHOTT PHARMA AG& CO KGAA / 1SXP Daily stock chart

1SXP.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 18.5 134.82B
1TMO.MI THERMO FISHER SCIENTIFIC INC 18.11 132.03B
DAP.DE DANAHER CORP 25.46 119.72B
LO3.DE LONZA GROUP AG-REG 38.03 44.15B
DIM.PA SARTORIUS STEDIM BIOTECH 51.05 18.88B
56S1.DE SARTORIUS STEDIM BIOTECH 50.79 18.78B
SRT3.DE SARTORIUS AG-VORZUG 49.41 15.80B
SRT.DE SARTORIUS AG 40.42 12.92B
ILU.DE ILLUMINA INC 24.8 11.54B
ERF.PA EUROFINS SCIENTIFIC 32.63 10.70B
ESF0.DE EUROFINS SCIENTIFIC 32.53 10.67B
QIA.DE QIAGEN N.V. 19.58 8.61B

About 1SXP.DE

Company Profile

1SXP logo image SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.

Company Info

SCHOTT PHARMA AG& CO KGAA

Hattenbergstrasse 10

MAINZ HESSEN DE

Employees: 4681

1SXP Company Website

1SXP Investor Relations

Phone: 496131660

SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ

What is the stock price of SCHOTT PHARMA AG& CO KGAA today?

The current stock price of 1SXP.DE is 28.5 EUR. The price increased by 1.42% in the last trading session.


What is the ticker symbol for SCHOTT PHARMA AG& CO KGAA stock?

The exchange symbol of SCHOTT PHARMA AG& CO KGAA is 1SXP and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is 1SXP.DE stock listed?

1SXP.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for SCHOTT PHARMA AG& CO KGAA stock?

19 analysts have analysed 1SXP.DE and the average price target is 28.98 EUR. This implies a price increase of 1.68% is expected in the next year compared to the current price of 28.5. Check the SCHOTT PHARMA AG& CO KGAA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SCHOTT PHARMA AG& CO KGAA worth?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a market capitalization of 4.29B EUR. This makes 1SXP.DE a Mid Cap stock.


How many employees does SCHOTT PHARMA AG& CO KGAA have?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4681 employees.


What are the support and resistance levels for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a support level at 24.7 and a resistance level at 28.51. Check the full technical report for a detailed analysis of 1SXP.DE support and resistance levels.


Is SCHOTT PHARMA AG& CO KGAA (1SXP.DE) expected to grow?

The Revenue of SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is expected to grow by 5.25% in the next year. Check the estimates tab for more information on the 1SXP.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCHOTT PHARMA AG& CO KGAA (1SXP.DE) stock pay dividends?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 0.57%. The yearly dividend amount is currently 0.15. Check the full fundamental report for a detailed analysis of 1SXP.DE dividend history, reliability and sustainability.


When does SCHOTT PHARMA AG& CO KGAA (1SXP.DE) report earnings?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of SCHOTT PHARMA AG& CO KGAA (1SXP.DE)?

The PE ratio for SCHOTT PHARMA AG& CO KGAA (1SXP.DE) is 29.08. This is based on the reported non-GAAP earnings per share of 0.98 and the current share price of 28.5 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1SXP.DE.


1SXP.DE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to 1SXP.DE. When comparing the yearly performance of all stocks, 1SXP.DE is one of the better performing stocks in the market, outperforming 76.93% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

1SXP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1SXP.DE Financial Highlights

Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.98. The EPS decreased by -32.93% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.17%
ROA 9.93%
ROE 17.64%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%52.94%
Sales Q2Q%7.95%
EPS 1Y (TTM)-32.93%
Revenue 1Y (TTM)-28.74%

1SXP.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to 1SXP.DE. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 4.94% and a revenue growth 5.25% for 1SXP.DE


Ownership
Inst Owners18.96%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts74.74
Price Target28.98 (1.68%)
EPS Next Y4.94%
Revenue Next Year5.25%